Fagron sales growth slows slightly in first quarter

April 9, 2015 5:21 AM

12 0

BRUSSELS, April 9 (Reuters) - Pharmaceutical group Fagron said sales growth in the first quarter slowed slightly from the second half of last year, but maintained its full-year outlook.

The company, which makes ingredients for pharmacists to make bespoke medicines, said sales in the first quarter increased by 29.8 percent from last year to 117.8 million euros ($126.92 million).

Also read: The 10 Highest-Paid Software and Services CEOs

Read more

To category page